404 - Page Not Found | Medical Board of California
The Medical Board of California's newsroom page returns a 404 error, indicating potential removal or restructuring of regulatory updates. This may affect access to recent changes in supervision requirements, scope of practice, or medical director rules for med-spas.
Aforeworn detected this change in the Med-Spa & Aesthetics Clinics space on July 5, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. All California med-spa and aesthetics clinics, especially those relying on MBC news for compliance updates. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Within 1 week to ensure no missed compliance deadlines.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Med-Spa & Aesthetics Clinics continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
The MBC newsroom page is inaccessible, potentially hiding recent regulatory changes or guidance.
Who it affects
All California med-spa and aesthetics clinics, especially those relying on MBC news for compliance updates.
What you must do
Monitor MBC website for restoration or alternative sources; check other official channels for updates.
Deadline
Within 1 week to ensure no missed compliance deadlines.
Source: https://www.mbc.ca.gov/About/Newsroom/
Never miss a change like this again
Aforeworn watches Med-Spa & Aesthetics Clinics around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Med-Spa & Aesthetics Clinics
- FDA Approves Labeling Changes for Over-the-Counter (OTC) Weight Loss Drug alli (Orlistat) to Warn of Risk of Kidney Stones and Kidney Injury
- Accolade Pacemaker Devices by Boston Scientific and Potential Need for Early Device Replacement - FDA Safety Communication
- Heart Pump Correction: Abiomed Issues Correction for Automated Impella Controllers
- Disruptions in Availability of Breast Biopsy Needles - Letter to Health Care Providers
- UPDATE: Hintermann Series H3 Total Ankle Replacement Has a Higher-Than-Expected Risk of Device Failure: FDA Safety Communication